To this end, Syneos Health helps support pharma organisations to “join the dots” by offering end-to-end clinical and commercial services through its Biopharmaceutical Acceleration Model.

The current international financing architecture is inadequate to address the multiple, intersecting crises that disproportionately impact those with the least power ...

Now the Royal Australian Navy has disclosed its plans to acquire two new classes of nuclear-powered submarines – the US-made ...

Decentralised clinical trials can drive efficiency and patient centricity, but only if the sector learns to join the dots between stakeholders. Hybrid and decentralised clinical trials (DCTs ...